Immunohistochemistry Global Market Report 2022: Rising Research and Development Activities for the Development of Innovative Products Drives Growth – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Immunohistochemistry Market, by Product, by Application, by End User by Region, – Size, Share, Outlook, and Opportunity Analysis, 2022-2030” report has been added to ResearchAndMarkets.com’s offering.

In histology, immunohistochemistry (IHC) is used to identify the presence of a particular protein marker that can aid in the accurate classification and diagnosis of tumors. Antibodies are used in immunohistochemistry (IHC) to locate proteins and other antigens in tissue sections. Either chromogenic detection using a colored enzyme substrate or fluorescence detection with a fluorescent dye is used to observe antibody-antigen interaction.

Market Dynamics

The increasing prevalence of chronic diseases, rising research and development activities for the development of innovative products, and increasing adoption of inorganic growth strategies such as mergers, acquisitions, partnerships, and collaborations by key players operating in market are the major factors that are expected to drive growth of the global immunohistochemistry market over the forecast period.

For instance, in June 2022, Lupin, an India-based biopharmaceutical company, announced the opening of its first regional reference laboratory in Patna, Bihar. A wide range of standard and specialist tests in the disciplines of molecular diagnostics, cytology, microbiology, serology, hematology, immunology, and normal biochemistry can be performed at the new regional reference laboratory in Patna.

According to an article by the Elsevier Inc., published in July 2021, the contribution of non-communicable neurological disorders to total disability-adjusted life-years (DALYs) in India doubled from 4 – 0% in 1990 to 8 – 2% in 2019. In addition, the largest contributors to the total neurological disorder DALYs in India were brain stroke (37 – 9%), headache disorders (17 – 5%), epilepsy (11 – 3%), cerebral palsy (5 – 7%), and encephalitis (5 – 3%), in 2019.

Key features of the study:

• This report provides in-depth analysis of the global immunohistochemistry market, and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2022-2030), considering 2021 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global immunohistochemistry market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
• Key companies covered as a part of this study include Merck, Rockland Immunochemicals, Inc., F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific, PerkinElmer, Inc., Bio-Rad Laboratories, Inc., Cell Signaling Technology, Inc., Bio SB, Agilent Technologies, Inc., Abcam plc., Becton, Dickinson and Company, Miltenyi Biotec, Biocare Medical, LLC, Eagle Biosciences, Inc., Bio-Techne, Diagnostic Biosystems, Inc., and BioGenex
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global immunohistochemistry market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global immunohistochemistry market

Detailed Segmentation:

Global Immunohistochemistry Market, By Product:

• Antibodies
• Consumables
• Equipment

Global Immunohistochemistry Market, By Application:

• In Vitro Diagnostic Applications
• Research Applications
• Others

Global Immunohistochemistry Market, By End User:

• Hospitals
• Diagnostic Laboratories
• Academic & Research Institutes
• Others

Global Immunohistochemistry Market, By Region:

• North America
• By Country
• U.S.
• Canada
• Latin America
• By Country
• Brazil
• Mexico
• Argentina
• Rest of Latin America
• Europe
• By Country
• Germany
• U.K.
• France
• Italy
• Spain
• Russia
• Rest of Europe
• Asia Pacific
• By Country
• China
• India
• Japan
• Australia
• South Korea
• ASEAN
• Rest of Asia Pacific
• Middle East
• By Country
• GCC
• Israel
• Rest of Middle East
• Africa
• By Country
• South Africa
• Central Africa
• North Africa

Company Profiles

• Merck
• Rockland Immunochemicals, Inc.
• F.Hoffman-la Roche Ltd
• Thermo Fisher Scientific
• PerkinElmer, Inc.
• Bio-Rad Laboratories
• Cell Signaling Technologies
• Bio SB
• Agilent Technologies, Inc.
• Abcam, PLC
• Becton, Dickinson and Company
• Miltenyi Biotec
• Biocare Medical, LLC
• Eagle Biosciences, INC.
• Bio-Techne
• Diagnostic Biosystems, Inc.
• BioGenex

Key Topics Covered:

1. Research Objectives and Assumptions

2. Market Purview

3. Market Dynamics, Regulations, and Trends Analysis

4. Global Immunohistochemistry Market – Impact of Coronavirus (Covid-19) Pandemic

5. Global Immunohistochemistry Market, By Product Type, 2017 – 2030, (US$ Mn)

6. Global Immunohistochemistry Market, By Application, 2017 – 2030, (US$ Mn)

7. Global Immunohistochemistry Market, By End User, 2017 – 2030, (US$ Mn)

8. Global Immunohistochemistry Market, By Region, 2017 – 2030, (US$ Mn)

9. Competitive Landscape

10. Section

For more information about this report visit https://www.researchandmarkets.com/r/36a7q3

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T. Office Hours Call 1-917-300-0470

For U.S./ CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900